131.85
-0.10
(-0.08%)
At close: January 24 at 4:49:15 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 2 | 23 | 24 |
| Avg. Estimate | 14.19B | 13.24B | 53.32B | 56.82B |
| Low Estimate | 13.85B | 12.94B | 52.6B | 54.16B |
| High Estimate | 14.64B | 13.54B | 53.84B | 59.58B |
| Year Ago Sales | 12.02B | 12.68B | 45.81B | 53.32B |
| Sales Growth (year/est) | 18.04% | 4.40% | 16.39% | 6.56% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ZEG.F | -- | -- | -- | -- |
| S&P 500 | 9.90% | 11.00% | 14.01% | 13.54% |
Related Tickers
JNJ.CL Johnson & Johnson
626,500.00
0.00%
PFE.CL Pfizer Inc.
109,420.00
-2.16%
PFE.F Pfizer Inc.
24.73
-2.00%
SAN.PA Sanofi
100.16
+0.27%
BAYN.DE Bayer Aktiengesellschaft
20.90
-0.85%
ROG.SW Roche Holding AG
274.90
+0.18%
BIIB Biogen Inc.
146.20
+1.76%
ABBV AbbVie Inc.
170.30
-0.22%
MRK Merck & Co., Inc.
95.55
-1.12%
PFE Pfizer Inc.
26.09
+0.31%